Adrenal gland – CLDN3 negative adrenocortical adenoma
Adrenal gland – CLDN3 negative pheochromocytoma
Breast – Invasive breast cancer of no special type (NST) with strong CLDN3 staining of tumor cells
Breast – Invasive lobular breast cancer with a moderate to strong CLDN3 staining of tumor cells
Colon – Colorectal adenocarcinoma with strong CLDN3 immunostaining of tumor cells
Esophagus – Adenocarcinoma with only a faint membranous CLDN3 staining of few tumor cells
Esophagus – Adenocarcinoma with strong CLDN3 immunostaining of tumor cells
Esophagus – CLDN3 negative squamous cell carcinoma
Kidney – Chromophobe renal cell carcinoma with a weak CLDN3 staining of few tumor cells
Kidney – CLDN3 negative clear cell carcinoma
Kidney – Clear cell renal cell carcinoma showing a weak strong CLDN3 staining of tumor cells
Kidney – Papillary renal cell carcinoma with strong CLDN3 immunostaining of tumor cells
Liver – Cholangiocellular carcinoma with intense CLDN3 positivity of all tumor cells
Liver – Hepatocellular carcinoma with strong CLDN3 staining of tumor cells
Lung – Adenocarcinoma with strong CLDN3 positivity of all tumor cells
Lymph node – CLDN3 negative Hodgkin’s lymphoma
Ovary – Clear cell carcinoma with strong CLDN3 staining of tumor cells
Ovary – Serous high-grade carcinoma with strong CLDN3 staining of tumor cells
Pancreas – Adenocarcinoma of the papilla Vaterii with strong CLDN3 staining of tumor cells
Pancreas – CLDN3 negative ductal adenocarcinoma. CLDN3 positivity is seen in adjacent non-neoplastic cells
Pancreas – CLDN3 negative ductal adenocarcinoma
Pancreas – Ductal adenocarcinoma with faint CLDN3 staining of tumor cells
Pancreas – Neuroendocrine tumor showing a strong CLDN3 staining of 100_ of tumor cells
Penis – CLDN3 negative squamous cell carcinoma
Pharynx – CLDN3 negative squamous cell carcinoma
Prostate – Adenocarcinoma (Gleason 3+3=6) with strong CLDN3 staining of tumor cells
Prostate – Adenocarcinoma (Gleason 5+5=10) with strong CLDN3 staining of tumor cells. Staining is markedly stronger than in intermingled non-neoplastic atrophic cells
Salivary gland – Warthin tumor with a moderate CLDN3 staining of tumor cells
Salivary gland – Warthin tumor with a weak to moderate CLDN3 staining of tumor cells. In addition, a strong staining occurs in cell groups within lymphatic tissue
Salivary gland – Warthin tumor with faint CLDN3 staining of luminal membranes of tumor cells. In addition, a strong staining occurs in cell groups within lymphatic tissue
Stomach – CLDN3 negative gastric adenocarcinoma (diffuse type)
Stomach – CLDN3 negative gastrointestinal stromal tumor (GIST)
Stomach – CLDN3 negative gastrointestinal stromal tumor (GIST)
Stomach – Gastric adenocarcinoma (diffuse type) with strong CLDN3 staining of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with intense CLDN3 positivity of tumor cells
Stomach – Gastric adenocarcinoma (intestinal type) with strong CLDN3 positivity of most tumor cells
Testis – CLDN3 negative embryonal carcinoma
Testis – CLDN3 negative seminoma
Urinary bladder – CLDN3 negative muscle-invasive urothelial carcinoma
Urinary bladder – Muscle-invasive urothelial carcinoma with strong CLDN3 positivity of tumor cells
Uterus, cervix – Adenocarcinoma with strong CLDN3 immunostaining of most tumor cells
Vagina – Squamous cell carcinoma with strong CLDN3 positivity of all tumor cells